The Kroger Co.: Attractive Even In This Environment
Kroger's stock outpaces the S&P 500, driven by digital growth and own-brand success. Read why it's still a Buy despite mixed ...
Novartis After Sandoz: The Business Without Generics
Novartis is thriving with double-digit growth, driven by key drugs in oncology, cardiology, immunology, and neurology. See ...